Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain.

J Neuropathol Exp Neurol

Clinical Neuroscience, Perinatal Research Centre, The University of Queensland Centre for Clinical Research, The University of Queensland, Herston, Australia.

Published: January 2011

AI Article Synopsis

  • The study investigates the effects of neonatal hypoxia-ischemia (HI) on the serotonergic system in the preterm brain, highlighting a decrease in serotonergic neurons and transporter levels after injury.
  • It finds that minocycline, a microglial inhibitor, significantly mitigates damage to the serotonergic network, particularly in regions with active neuroinflammation, suggesting a protective role against HI-induced injury.
  • These findings imply that targeting neuroinflammation could be a potential therapeutic strategy to preserve serotonergic function in preterm neonates, despite concerns regarding minocycline use in these populations.

Article Abstract

The phenotypic identities and characterization of neural networks disrupted after neonatal hypoxia-ischemia (HI) in the preterm brain remain to be elucidated. Interruption of the central serotonergic (5-hydroxytryptamine [5-HT]) system can lead to numerous functional deficits, many of which match those in human preterm neonates exposed to HI. How the central serotonergic network is damaged after HI and mechanisms underlying such injury are not known. We used a Postnatal Day 3 rat model of preterm HI and found parallel reductions in the 5-HT transporter expression, 5-HT levels and numbers of 5-HT-positive dorsal raphe neurons 1 week after insult. Post-HI administration of minocycline, an inhibitor of activated microglia, attenuated HI-induced damage to the serotonergic network. Minocycline effects seemed to be region specific, that is, where there was micro-glial activation and increases in tumor necrosis factor-α and inter-leukin 1β. The concurrent improvement in serotonergic outcomes suggests that inhibition of neuroinflammation prevented damage to the serotonergic neurons rather than affected the regulation of 5-HT or serotonin transporter. These data elucidate the mechanisms of serotonergic network injury in HI, and despite the known adverse effects associated with the use of minocycline in neonates, postinsult administration of minocycline may represent a novel approach to counter neuroinflammation and preserve the integrity of the central serotonergic network in the preterm neonate.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0b013e3182020b7bDOI Listing

Publication Analysis

Top Keywords

serotonergic network
20
central serotonergic
12
inhibition neuroinflammation
8
serotonergic
8
administration minocycline
8
damage serotonergic
8
network
5
neuroinflammation prevents
4
prevents injury
4
injury serotonergic
4

Similar Publications

Ethnopharmacological Relevance: Alzheimer's disease (AD) is an incurable neurodegenerative disease that has become one of the most important diseases threatening global public health security. Dihuang Yinzi (DHYZ) is a traditional Chinese medicine that has been widely used for the treatment of AD and has significant therapeutic effects, but its specific mechanism of action is still unclear.The aim of the study is to investigate the specific mechanism of DHYZ in treating AD based on brain metabolomics and network pharmacology.

View Article and Find Full Text PDF
Article Synopsis
  • Traditional Chinese medicine (TCM), particularly Zhi-Zi-Hou-Pu Decoction (ZZHPD), shows promise in treating depression, but its mechanisms have not been fully explored.
  • The study employed network pharmacology and molecular docking to uncover pharmacological targets related to ZZHPD and its active compounds, finding significant interactions affecting inflammation and neuroimmune cell functions.
  • Key findings include the identification of 18 active compounds, particularly honokiol and eriocitrin, along with implications for drug interactions that could affect treatment effectiveness and side effects in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • Serotonergic psychedelics, like LSD and psilocybin, alter consciousness and may help treat mental health issues, but how they work is still not entirely clear.
  • The study reviews subjective experiences, neuroimaging, and molecular actions, indicating LSD leads to more intense visionary experiences compared to psilocybin and alters brain connectivity patterns.
  • Findings suggest a complex relationship between different psychedelics' effects and highlight the need for standardized research methods to better understand these substances and their therapeutic potential.*
View Article and Find Full Text PDF

Dravet syndrome (DS) is a severe genetic developmental and epileptic encephalopathy, primarily caused by SCN1A gene mutations. Historically, treatments like clobazam and valproate have been used without evidence from randomized controlled trials (RCTs). However, the therapeutic landscape of DS has evolved with multiple RCTs demonstrating the efficacy and safety of three antiseizure medications (ASMs): stiripentol, cannabidiol (CBD), and fenfluramine.

View Article and Find Full Text PDF

Kisspeptins are reported to be the most potent activators of the hypothalamus-pituitary-gonadal (HPG) axis known to date. Kisspeptin potently elicits gonadotropin-releasing hormone (GnRH) release and luteinizing hormone (LH) secretion, even in the pre-pubertal period. Beyond the hypothalamus, kisspeptin is also expressed in limbic and paralimbic brain regions, which are areas of the neurobiological network primarily implicated in emotional behaviors alongside sexual functions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!